Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma. - Wikidata - awgldk - TriplyDB

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

http://www.wikidata.org/entity/Q33563921

about

Identification of key genes and pathways in uterine leiomyosarcoma through bioinformatics analysis.Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans.

P2860

Q55342255-9F3D2E44-DCA3-447F-A827-21409465B5DE Q55714722-508254B2-5EEA-4D73-ADE1-F7CF6AEAEE3A

P2860

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

http://www.wikidata.org/entity/Q33563921

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@ast

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@en

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@nl

type

label

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@ast

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@en

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@nl

prefLabel

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@ast

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@en

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.

@nl

P1433

Q33563921-10B295FA-4593-4729-810E-2F83F604DC61

P1476

Q33563921-4DF758F7-F7FE-4A53-B236-702EAA9701EA

P2093

Q33563921-128884C4-ADD7-4A90-B55F-FDD1EE45C53C

Q33563921-87B0FB95-AA4C-4D3F-9960-A4031780854F

Q33563921-C19C6126-01A7-421B-9933-902F57CFAED4

P2860

Q33563921-09D6146E-D725-4AF2-88FE-212D4B3F29D2

Q33563921-1765B0DE-4A42-4A9C-98D2-1CD725E41978

Q33563921-17ACC5FB-D38D-41F7-A71C-A39FAA97AA6E

Q33563921-17DD4955-581C-4088-80BA-A5F2B3BD67AB

Q33563921-19B3499B-62BD-4AE4-8C5B-077E2FD1290E

Q33563921-223A65FB-DF4E-4910-8188-CD2820E74DF3

Q33563921-34C64249-F515-4CFC-8394-1BADB6458717

Q33563921-3B3BF4B8-28F7-4BFB-8C30-B28D464F17F6

Q33563921-47843801-4C15-4AC3-9C02-D757A47CD3B4

Q33563921-4E1E142C-BDBA-40B6-B57D-7FADBCAE933D

P304

Q33563921-B7E4799C-16A5-4783-8311-DD54FF0EAD8E

P31

Q33563921-4AAC8D3F-5AB4-4B01-B497-ABE0239332AE

P356

Q33563921-CAE1CA79-81D6-4131-A1A4-ED018C094829

P433

Q33563921-BE0D7AF1-4AC0-478E-A270-AB9C8881AE35

P478

Q33563921-E8391208-288E-4293-BC1E-09863CB1A1A5

P50

Q33563921-0F711F58-E171-423C-8A6F-5C88D0D620EF

Q33563921-18347E1D-4180-4E2A-A1B8-0C57CB4B6713

Q33563921-6A26E954-2B3C-43BE-A6FA-62CF1DA392F6

Q33563921-9E56A076-8B2D-4B41-9BE8-742863A01872

Q33563921-BC2C3BCE-30D1-4726-946D-18E4C86003D5

P577

Q33563921-D4591E74-3DB0-4AB7-9C84-C7DCA7F2323C

P698

Q33563921-AAC5EA3E-FCC6-47EE-ABF0-73829A989C88

P932

Q33563921-41D9968B-050A-473E-8D9F-C4312DE757D5

P356

JGO.2017.28.E28

P1433

Journal of gynecologic oncology

P1476

Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma

@en

P2093

Hyun Ju Lee

http://www.w3.org/2001/XMLSchema#string

Jong Jin Lee

http://www.w3.org/2001/XMLSchema#string

Seung Hwan Moon

http://www.w3.org/2001/XMLSchema#string

P2860

The management of patients with uterine sarcoma: a debated clinical challenge

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Uterine sarcomas: a review.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.

Risk assessment based on FDG-PET imaging in patients with synovial sarcoma

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.

Morcellation and myomas: Balancing decisions around minimally invasive treatments for fibroids.

Basic principles of ROC analysis.

P304

e28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2017.28.E28

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Jeong-Yeol Park

Hyun Hoon Chung

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28382795

http://www.w3.org/2001/XMLSchema#string

P932

5391391

http://www.w3.org/2001/XMLSchema#string